A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, Application In Synthesis of (1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 68737-65-5, Name is (1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine, molecular formula is C8H18N2. In a Patent, authors is £¬once mentioned of 68737-65-5
PERFLUORINATED 5,6-DIHYDRO-4H-1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: wherein variables A4, A5, A6, A8, each of R1 and R2, R3 and R7 of Formula I, independently, are defined herein. The invention also provides pharmaceutical compositions comprising the compounds, and corresponding uses of the compounds and compositions for treatment of disorders and/or conditions related to A-beta plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer’s Disease, cognitive deficits, cognitive impairments, schizophrenia and other central nervous system conditions. The invention further provides compounds of Formulas II and III, and sub-formula embodiments thereof, intermediates and processes and methods useful for the preparation of compounds of Formulas I-III.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 68737-65-5, help many people in the next few years.Application In Synthesis of (1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine
Reference£º
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI